Molecular targeted therapy for hepatocellular carcinoma: present status and future directions

KJ Choi, IH Baik, SK Ye, YH Lee - Biological and Pharmaceutical …, 2015 - jstage.jst.go.jp
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most lethal
neoplasm, causing an estimated 700000 deaths annually. Currently HCC has only one …
被引用次数：89 相关文章

[引用][C] Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions

K CHOI, IH BAIK, S YE, Y LEE - Biological and Pharmaceutical …, 2015 - jglobal.jst.go.jp
Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future
Directions | Article Information | J-GLOBAL Art J-GLOBAL ID:201502207598905057 …
[HTML] jst.go.jp

[HTML][HTML] Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions

KJ Choi, IH Baik, SK Ye, YH Lee - Biological and Pharmaceutical …, 2015 - jstage.jst.go.jp
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most lethal
neoplasm, causing an estimated 700000 deaths annually. Currently HCC has only one …

Molecular targeted therapy for hepatocellular carcinoma: Present status and future directions

KJ Choi, IH Baik, SK Ye, YH Lee - Biological and …, 2015 - snucm.elsevierpure.com
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most lethal
neoplasm, causing an estimated 700000 deaths annually. Currently HCC has only one …

Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions

KJ Choi, IH Baik, SK Ye, YH Lee - Biological & …, 2015 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most lethal
neoplasm, causing an estimated 700000 deaths annually. Currently HCC has only one …

Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions

C Kyung-Ju, BI Hye, Y Sang-Kyu… - … & Pharmaceutical Bulletin, 2015 - cir.nii.ac.jp
抄録 Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most
lethal neoplasm, causing an estimated 700000 deaths annually. Currently HCC has only …
[PDF] researchgate.net

[PDF][PDF] Current Research Trends in the Exploration of Therapeutic Targets for Liver Disease

KJ Choi, IH Baik, SK Ye, YH Lee - Biol. Pharm. Bull, 2015 - researchgate.net
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most lethal
neoplasm, causing an estimated 700000 deaths annually. Currently HCC has only one …

Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions

KJ Choi, IH Baik, SK Ye, YH Lee - Biological and Pharmaceutical Bulletin, 2015 - jlc.jst.go.jp
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most lethal
neoplasm, causing an estimated 700000 deaths annually. Currently HCC has only one …
[PDF] archive.org

[PDF][PDF] Current Research Trends in the Exploration of Therapeutic Targets for Liver Disease

KJ Choi, IH Baik, SK Ye, YH Lee - Biol. Pharm. Bull, 2015 - scholar.archive.org
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most lethal
neoplasm, causing an estimated 700000 deaths annually. Currently HCC has only one …

Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions.

KJ Choi, IH Baik, SK Ye, YH Lee - Biological & Pharmaceutical …, 2015 - europepmc.org
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most lethal
neoplasm, causing an estimated 700000 deaths annually. Currently HCC has only one …